Failed Back Surgery Syndrome
Conditions
Keywords
Lower Level Laser Therapy (LLLT), inflammation, cytokines, wound healing, laminectomy, clinical study
Brief summary
Each year, more than one million individuals worldwide are submitted to laminectomies, with a failure rate higher than 40%. Postlaminectomy epidural adhesion is implicated as a main cause of ''failed back surgery syndrome'' and associated with increased risk of complications during revision surgery. The postoperative epidural scar can cause extradural compression or dural tethering, which results in recurrent radicular pain and physical impairment. Several studies in the literature are signalizing that Low-Level-Laser-Therapy (LLLT) is proven to be an effective tool to assist the inflammatory process and wound healing, as well to prevent infection. Thus, the objectives of this project are to delineate and evaluate the LLLT effects in spinal surgery. A prospective randomized, controlled trial with a total of 48 patients who underwent laminectomy, were divided into 2 groups. In the first group, 25 patients received LLLT during the surgical procedure over dura mater, over subcutaneous and on the skin, as well as 24h and 72h post surgery. In the second group, 23 patients were induced to think they will be getting the same treatment, although the laser is not operating. In those groups, C reactive protein, Lactate Dehydrogenase and Creatine kinase were evaluated in the second and fifth days after surgery, digital temperature will be measured and scores in visual analogue scale will be used, 5 minutes pre and 5 minutes post Laser application. The drainage output was collected in the first three days following surgery in both groups. Interleukins were evaluated in interstitial infiltrate drained in 24h and 48h. The data was evaluated for normality and subjected to appropriate statistical analysis, in order to seek representation, as same as the level of significance of the studied samples.
Interventions
RADIATIONLow Level Laser Therapy
In 23 randomized patients, LLLT (B-Cure, Good Energies ®, Israel), with CW diode laser - semiconductor Gallium Arsenide and aluminum (GaAlAs) will be applied during surgery (λ = 804 nm ± 2 , total exposure time of 240 s, energy density of 2.48 J/cm2 , average power of 40 mW , spot area of 3,876 cm2), in contact mode, for 60 seconds on the laminectomy site, 60 seconds and 120 seconds in the subcutaneous tissue of the skin over the wound bed, respectively. In the first and second day post surgery, will be collected the drainage output for analysis of interleukin 1, 4, 6, 8 and 10 (IL- 1, IL-4, IL -6, IL-8 and IL -10 ) and tumor necrosis factor alpha ( TNF -alpha ).
PROCEDUREPlacebo
In the operating room, lumbar laminectomy will be performed in 46 patients. During the surgery, 24 hours and 48 hours after surgery, the patients received the regular treatment after laminectomy and were induced to thing that were receiving low level laser therapy in their wound.
Sponsors
University of Nove de Julho
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
10 Years to 90 Years
Healthy volunteers
Yes
Inclusion criteria
* Patients undergoing to lumbar laminectomy
Exclusion criteria
* Active lumbar cancer * Infectious disease * Coagulation disorders * Dural injury during the surgery
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Immunochemistry to evaluate low level laser therapy mechanism 48 hours after light delivery | 48h after surgery | Interstitial infiltrate was obtained of Lumbar Drain collected 48 hours after surgery, in this infiltrate interleukins IL-1, IL-4, IL-8, IL10 and TNF alfa were measured through Immunochemistry, using ELISA. |
| Immunochemistry to evaluate low level laser therapy anti-inflammatory mechanism 24 hours | 24 hours after surgery | Interstitial infiltrate obtained of Lumbar Drain collected 24 hours after surgery, interleukins IL-1, IL-4, IL-8, IL-10 and TNF alfa were measured through Immunochemistry, using ELISA. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Score in Visual Analogue Scale | 5 minutes pre LLLT | Patient had to choose between 0 and 10 on the 11 point short pain scale. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Values of Lactate dehydrogenase in the blood | pre operative, 24h and 48h postoperative | Obtained through patient blood pre operative, 24h and 48h postoperative |
| Values of Creatine Kinase in the blood | pre operative, 24h and 48h postoperative | Obtained through patient blood. |
| Temperature of the skin in the healing scar | pre and 1 minute post LLLT | Verified 1 minute before and 1 minute after LLLT |
| Values of C reactive protein in the blood | pre operative, 24h and 48h postoperative | Obtained through patient blood pre operative, 24h and 48h postoperative |
Countries
Brazil
Outcome results
None listed